SignalUS

Drug shortage: Amino Acid Injection (PREMASOL - SULFITE-FREE (AMINO ACID), AMINOSYN-PF, AMINOSYN II)

FDA lists 16 presentations as Current. Availability: Unavailable (3), Available (13). Reason: Shortage of an active ingredient; Shortage of an inactive ingredient component. Companies: Baxter Healthcare, Otsuka ICU Medical LLC, B. Braun Medical Inc..

Published by source
2020-12-08
First seen by Reality Radar
2026-10-22
Last verified
2026-10-23

Affected

Manufacturer
Baxter Healthcare
Products
Amino Acid Injection PREMASOL - SULFITE-FREE (AMINO ACID) AMINOSYN-PF AMINOSYN II TRAVASOL TROPHAMINE PLENAMINE

Whether your exact unit is affected depends on the model, serial number and region in the official notice.

What the official notice says

Risk: Current — Unavailable

Remedy / actions:

  • Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.

Is this affecting you?

Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.

Track it free

Sources

Evidence ledger

Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.

EntryKindObservedEvidence hashEntry hash
#898new2026-10-22bf1a972e461d…f78d45ffb7d5ee6e1b…ea4b59
#1145update2026-10-239344ba2dc0b0…2577cb1810018de2f2…52d845
#1374update2026-10-23bfd89c8c6a68…548a8521e9b32ac869…abc682

Chain head: #1479 ad3417dbc128…777bd4

Raw ledger entries (JSON) · Verify chain

Share this signal